Abstract
Interventional radiology is essential to the multidisciplinary liver transplant program. The goal of the interventional radiologist is to decrease the dropout rate from the transplant waiting list. Decreasing the dropout rate is accomplished twofold: (1) treating sequelae of portal hypertension and (2) treating hepatocellular carcinoma. The interventional radiologist has the knowledge base and skill set to treat sequelae of severe portal hypertension by creating transjugular intrahepatic portosystemic shunts (TIPS), thereby treating life-threatening hemorrhage and/or improving the patients’ quality of life. In patients with hepatocellular carcinoma, the interventional radiologist performs palliative therapies in order to maintain the disease within size and number criteria required for transplantation. In patients with hepatocellular carcinoma beyond transplant criteria, the same palliative therapies are performed to potentially downstage cancer so that patients become eligible for transplant candidacy. Numerous prospective and retrospective clinical trials, which will be discussed in this chapter, have shown the efficacy of procedures performed by interventional radiologists. Through a discussion of these procedures, an understanding of the critical role of interventional radiology for the pretransplant patient can be made.
References
Ahmed M, Brace CL, Lee FT, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258:351–369. doi:10.1148/radiol.10081634
Amesur NB, Zajko AB (2006) Interventional radiology in liver transplantation. Liver Transpl 12:330–351. doi:10.1002/lt.20731
Angermayr B, Cejna M, Karnel F et al (2003) Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52:879–885
Azoulay D, Castaing D, Dennison A et al (1994) Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 19:129–132
Bai M (2014) TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol 20:2704. doi:10.3748/wjg.v20.i10.2704
Bilbao JI, Quiroga J, Herrero JI, Benito A (2002) Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol 25:251–269. doi:10.1007/s00270-002-1912-2
Bilbao JI, Elorz M, Vivas I et al (2004) Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 27:474–480. doi:10.1007/s00270-004-0241-z
Blum U, Haag K, Rössle M et al (1995) Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195:153–157. doi:10.1148/radiology.195.1.7892458
Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases (2010) The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 51:306. doi:10.1002/hep.23383
Carr CE, Tuite CM, Soulen MC et al (2006) Role of ultrasound surveillance of transjugular intrahepatic portosystemic shunts in the covered stent era. J Vasc Interv Radiol 17:1297–1305. doi:10.1097/01.RVI.0000231951.47931.82
Casado M, Bosch J, GarcĂa-Pagán JC et al (1998) Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114:1296–1303
Cescon M, Cucchetti A, Ravaioli M, Pinna AD (2013) Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. J Hepatol 58:609–618. doi:10.1016/j.jhep.2012.09.021
Charon J-PM, Alaeddin FH, Pimpalwar SA et al (2004) Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 15:1219–1230. doi:10.1097/01.RVI.0000137434.19522.E5
Clavien PA, Lesurtel M, Bossuyt PM et al (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13:e11–e22. doi:10.1016/S1470-2045(11)70175-9
Copelan A, Kapoor B, Sands M (2014) Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Interv Radiol 31:235–242. doi:10.1055/s-0034-1382790
Cura M, Cura A, Suri R et al (2008) Causes of TIPS dysfunction. AJR Am J Roentgenol 191:1751–1757. doi:10.2214/AJR.07.3534
Ferral H (2005) The evaluation of the patient undergoing an elective transjugular intrahepatic portosystemic shunt procedure. Semin Interv Radiol 22:266–270. doi:10.1055/s-2005-925552
Ferral H, Bilbao JI (2005) The difficult transjugular intrahepatic portosystemic shunt: alternative techniques and “tips” to successful shunt creation. Semin Interv Radiol 22:300–308. doi:10.1055/s-2005-925556
Ferral H, Gamboa P, Postoak DW, et al (2004a) Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 231:231–236. doi: 10.1148/radiol.2311030967
Ferral H, Gamboa P, Postoak DW, et al (2004b) Survival after elective transjugular intrahepatic portosystemic shunt creation: Prediction with model for end-stage liver disease score1. Radiology 231:231–236. doi: 10.1148/radiol.2311030967
Gaba RC, Khiatani VL, Knuttinen MG et al (2011) Comprehensive review of TIPS technical complications and how to avoid them. AJR Am J Roentgenol 196:675–685. doi:10.2214/AJR.10.4819
Gaba RC, Omene BO, Podczerwinski ES et al (2012) TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol 23:227–235. doi:10.1016/j.jvir.2011.10.015
GarcĂa-Pagán JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–2379. doi:10.1056/NEJMoa0910102
Garcia-Pagán JC, Di Pascoli M, Caca K et al (2013) Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 58:45–50. doi:10.1016/j.jhep.2012.08.020
Habib A, Desai K, Hickey R et al (2015) Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 26:499–506. doi:10.1016/j.jvir.2014.12.012
Haskal ZJ, Martin L, Cardella JF et al (2003) Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 14:S265–S270
Hinshaw JL, Lubner MG, Ziemlewicz TJ et al (2014) Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation – what should you use and why? Radiographics 34:1344–1362. doi:10.1148/rg.345140054
Jaskolka JD, Asch MR, Kachura JR et al (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16:485–491. doi:10.1097/01.RVI.0000151141.09597.5F
Kalva SP, Salazar GM, Walker TG (2009) Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage. Tech Vasc Interv Radiol 12:92–101. doi:10.1053/j.tvir.2009.08.003
Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470. doi:10.1053/jhep.2001.22172
Kandarpa K, Machan L (eds) (2011) Handbook of interventional radiologic procedures. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia
Kluger MD, Halazun KJ, Barroso RT et al (2014) Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl 20:536–543. doi:10.1002/lt.23846
Lencioni R, Crocetti L (2012) Local-regional treatment of hepatocellular carcinoma. Radiology 262:43–58. doi:10.1148/radiol.11110144
Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920–1928. doi:10.1111/j.1600-6143.2009.02695.x
Lewandowski RJ, Geschwind J-F, Liapi E, Salem R (2011) Transcatheter intraarterial therapies: rationale and overview. Radiology 259:641–657. doi:10.1148/radiol.11081489
Livraghi T, Lazzaroni S, Meloni F, Solbiati L (2005) Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92:856–858. doi:10.1002/bjs.4986
Llovet JM, Vilana R, Brú C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129. doi:10.1053/jhep.2001.24233
Llovet JM, Real MI, Montaña X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet (Lond) 359:1734–1739. doi:10.1016/S0140-6736(02)08649-X
Llovet JM, Ducreux M, Lencioni R et al (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943. doi:10.1016/j.jhep.2011.12.001
Lo C-M, Ngan H, Tso W-K et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171. doi:10.1053/jhep.2002.33156
Lopera JE (2005) Role of emergency transjugular intrahepatic portosystemic shunts. Semin Interv Radiol 22:253–265. doi:10.1055/s-2005-925551
Madoff DC, Wallace MJ (2005) Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. Semin Interv Radiol 22:316–328. doi:10.1055/s-2005-925558
Majno P, Lencioni R, Mornex F et al (2011) Is the treatment of hepatocellular carcinoma on the waiting list necessary? Liver Transpl 17(Suppl 2):S98–S108. doi:10.1002/lt.22391
Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871. doi:10.1053/he.2000.5852
Marelli L, Stigliano R, Triantos C, et al (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6–25. doi:10.1007/s00270-006-0062-3
Mazzaferro V, Bhoori S, Sposito C et al (2011) Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 17(Suppl 2):S44–S57. doi:10.1002/lt.22365
Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47(Suppl):S2–S6. doi:10.1097/MCG.0b013e3182872f29
Montgomery A, Ferral H, Vasan R, Postoak DW (2005) MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 28:307–312. doi:10.1007/s00270-004-0145-y
Nicolini A, Martinetti L, Crespi S et al (2010) Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 21:327–332. doi:10.1016/j.jvir.2009.10.038
Nicolini D, Svegliati-Baroni G, Candelari R et al (2013) Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol 19:5622–5632. doi:10.3748/wjg.v19.i34.5622
Padovani R, Bernardi G, Quai E et al (2005) Retrospective evaluation of occurrence of skin injuries in interventional cardiac procedures. Radiat Prot Dosimetry 117:247–250. doi:10.1093/rpd/nci757
Pan J-J, Chen C, Caridi JG et al (2008) Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years’ experience from a single tertiary medical center. J Vasc Interv Radiol 19:1576–1581. doi:10.1016/j.jvir.2008.07.021
Parikh ND, Waljee AK, Singal AG (2015) Downstaging hepatocellular carcinoma: a systematic review and pooled analysis. Liver Transpl 21:1142–1152. doi:10.1002/lt.24169
Pomier-Layrargues G, Bouchard L, Lafortune M et al (2012) The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status. Int J Hepatol 2012:1–12. doi:10.1155/2012/167868
Pompili M, Francica G, Ponziani FR et al (2013) Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol 19:7515–7530. doi:10.3748/wjg.v19.i43.7515
Rector WG (1986) Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 6:221–226
Riaz A, Kulik L, Lewandowski RJ et al (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49:1185–1193. doi:10.1002/hep.22747
Riaz A, Lewandowski RJ, Kulik L et al (2010) Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol 33:1143–1152. doi:10.1007/s00270-009-9766-5
Rösch J, Keller FS (2014) Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. World J Surg 25:337–344. doi:10.1007/s002680020380
Rossle M, Haag K, Ochs A et al (1994) The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171. doi:10.1056/NEJM199401203300303
Rössle M, Ochs A, Gülberg V et al (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342:1701–1707. doi:10.1056/NEJM200006083422303
Rossle M, Siegerstetter V, Olschewski M et al (2001) How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 96:3379–3383. doi:10.1111/j.1572-0241.2001.05340.x
Salem R, Lewandowski RJ, Kulik L et al (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140:497.e2–507.e2. doi:10.1053/j.gastro.2010.10.049
Salem R, Gilbertsen M, Butt Z et al (2013) Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol 11:1358.e1–1365.e1. doi:10.1016/j.cgh.2013.04.028
Salem R, Vouche M, Baker T et al (2015) Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis. Transplantation. doi:10.1097/TP.0000000000000729
Salerno F, Merli M, Cazzaniga M et al (2002) MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 36:494–500
Salerno F, Cammà C, Enea M et al (2007) Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133:825–834. doi:10.1053/j.gastro.2007.06.020
Sanyal AJ, Freedman AM, Purdum PP et al (1996) The hematologic consequencs of transjugular intrahepatic portosystemic shunts. Hepatology 23:32–39
Sanyal AJ, Genning C, Reddy KR et al (2003) The North American study for the treatment of refractory ascites. Gastroenterology 124:634–641. doi:10.1053/gast.2003.50088
Sawhney R, Wall SD (1998) TIPS complications. Tech Vasc Interv Radiol 1:80–85. doi:10.1016/S1089-2516(98)80037-1
Schepke M, Roth F, Fimmers R et al (2003) Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 98:1167–1174. doi:10.1111/j.1572-0241.2003.07515.x
Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337. doi:10.1148/radiol.2232010775
Stecker MS, Balter S, Towbin RB et al (2009) Guidelines for patient radiation dose management. J Vasc Interv Radiol 20:S263–S273. doi:10.1016/j.jvir.2009.04.037
Valji K (2006) Vascular and interventional radiology. Saunders Elsevier, Philadelphia
Van der Linden P, Le Moine O, Ghysels M et al (1996) Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 23:982–987. doi:10.1053/jhep.1996.v23.pm0008621179
Vogl TJ, Farshid P, Naguib NNN et al (2015) Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging 40:1829–1837. doi:10.1007/s00261-015-0355-6
Xu H-X, Xie X-Y, Lu M-D et al (2004) Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 59:53–61
Yao FY, Mehta N, Flemming J et al (2015) Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology 61:1968–1977. doi:10.1002/hep.27752
Zheng M, Chen Y, Bai J et al (2008) Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update. J Clin Gastroenterol 42:507–516. doi:10.1097/MCG.0b013e31815576e6
Zivin SP, Gaba RC (2014) Technical and practical considerations for device selection in locoregional ablative therapy. Semin Interv Radiol 31:212–224. doi:10.1055/s-0034-1373796
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Shamimi-Noori, S. (2017). Interventional Radiology for the Pre-transplant Patient. In: Doria, C. (eds) Contemporary Liver Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07209-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-07209-8_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07208-1
Online ISBN: 978-3-319-07209-8
eBook Packages: MedicineReference Module Medicine